Kissei Pharmaceutical Co., Ltd. has completed the disposal of 19,794 shares of treasury stock to directors and executive officers, with a total payment of 77,988,360 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4547","jir_company_name":"Kissei Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-07-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4547-20260723-01.pdf","jir_short_summary":"Kissei Pharmaceutical Co., Ltd. has completed the disposal of 19,794 shares of treasury stock to directors and executive officers, with a total payment of 77,988,360 yen.","jir_summary":"### Overview of Share Buyback\nKissei Pharmaceutical Co., Ltd. completed the sale of treasury stock with restrictions on transfer to eight directors and twelve executive officers on July 23, 2026. The number of shares disposed was 19,794, with a total disposal amount of 77,988,360 yen, and a per share disposal amount of 3,940 yen. The recipients were eight directors and twelve executive officers, and this was carried out as part of the company's capital policy to strengthen executive incentives and corporate governance.\n\n### Future Outlook and Impact on Shareholders\nThis share buyback is considered a measure aimed at enhancing director ownership awareness and increasing corporate value. The dilutive effect on shares from the disposal is limited, and the impact on shareholder value is expected to be minimal. The company will continue to pursue sustainable growth and strengthen governance, with a focus on shareholder returns and increasing corporate value.","jir_financial_highlights":"Number of shares disposed: 19,794 shares (Unknown)\nDisposal amount: 77,988,360 yen (Unknown)\nPer share disposal amount: 3,940 yen (Unknown)","jir_category":"","jir_hashtags":"#KisseiPharmaceutical, #TreasuryStock, #JapanStocks","jir_key_figures":"Number of shares disposed: 19,794 shares\nDisposal amount: 77,988,360 yen\nPer share disposal amount: 3,940 yen","jir_meta_title":"\u3010Kissei Pharmaceutical Co., Ltd.\u3011 Share Buyback Completed\uff5cJuly 2026","jir_meta_description":"Kissei Pharmaceutical Co., Ltd. completed a share buyback for officers on July 23, 2026, disposing of 19,794 shares with a total of 77,988,360 yen. The measure aims to strengthen officer incentives.","jir_og_title":"\u3010Kissei Pharmaceutical Co., Ltd.\u3011 Share Buyback Completed\uff5cJuly 2026","jir_og_description":"Kissei Pharmaceutical Co., Ltd. disposed of 19,794 shares of treasury stock to officers, raising 77,988,360 yen. Contributing to enhanced corporate governance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8930,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-87013","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n